These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model. Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903 [TBL] [Abstract][Full Text] [Related]
6. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model. Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664 [TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic. Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Li S; Han Q; Tan Y; Zhao M; Li Y; Nelson SD; Dry SM; Singh AS; Elliott IA; Russell TA; Eckardt MA; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM Cell Cycle; 2018; 17(6):801-809. PubMed ID: 29374999 [TBL] [Abstract][Full Text] [Related]
8. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide. Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068 [TBL] [Abstract][Full Text] [Related]
9. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model. Murakami T; DeLong J; Eilber FC; Zhao M; Zhang Y; Zhang N; Singh A; Russell T; Deng S; Reynoso J; Quan C; Hiroshima Y; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Chawla S; Endo I; Hoffman RM Oncotarget; 2016 Mar; 7(11):12783-90. PubMed ID: 26859573 [TBL] [Abstract][Full Text] [Related]
10. Recombinant Methioninase Combined With Tumor-targeting Igarashi K; Kawaguchi K; Zhao M; Han Q; Tan Y; Kiyuna T; Miyake K; Higuchi T; Nelson SD; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM Anticancer Res; 2020 May; 40(5):2515-2523. PubMed ID: 32366396 [TBL] [Abstract][Full Text] [Related]
11. Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Igarashi K; Kawaguchi K; Murakami T; Kiyuna T; Miyake K; Nelson SD; Dry SM; Li Y; Yanagawa J; Russell TA; Singh AS; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Eilber FC; Hoffman RM Cell Cycle; 2017 Jun; 16(12):1164-1170. PubMed ID: 28494180 [TBL] [Abstract][Full Text] [Related]
12. The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Higuchi T; Kawaguchi K; Miyake K; Oshiro H; Zhang Z; Razmjooei S; Wangsiricharoen S; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Nelson SD; Dry SM; Li Y; Chawla SP; Eilber FC; Singh SR; Tsuchiya H; Hoffman RM Biomed Pharmacother; 2019 Mar; 111():835-840. PubMed ID: 30616082 [TBL] [Abstract][Full Text] [Related]